The benefits of GLP1-RA therapy for blood glucose management are well known, but our research provides much-needed evidence in support of the [kidney]-protective effect of GLP1-RAs in high-risk patients with moderate to advanced chronic kidney disease, said study first author Dr
Grady RW, Galanello R, Randolph RE, Kleinert D, Dessi C, Giardina PJ
Feeling uncertain about the future of your GLP-1 medication
Debes acceder para publicar una valoracin
While animal studies extending to 6 weeks have found no concerning signals, humans using the peptide are essentially participating in uncontrolled self-experimentation regarding long-term outcomes
Most (pretty much all aside from a few) dont cover GLP-1s for weight loss